TARS Tarsus Pharmaceuticals Inc

$54.61

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/18/2025

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions. The company is headquartered in Irvine, California.

Website: https://www.tarsusrx.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1819790
Address
15440 LAGUNA CANYON ROAD, IRVINE, CA, US
Valuation
Market Cap
$2.05B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
9.13
Performance
EPS
$-3.07
Dividend Yield
—
Profit Margin
-63.20%
ROE
-54.80%
Technicals
50D MA
$48.14
200D MA
$41.33
52W High
$57.28
52W Low
$20.08
Fundamentals
Shares Outstanding
42M
Target Price
$70.75
Beta
0.94

TARS EPS Estimates vs Actual

● Estimated
● Actual

TARS News & Sentiment

Aug 06, 2025 • Zacks Commentary NEUTRAL
Tarsus Pharmaceuticals, Inc. ( TARS ) Reports Q2 Loss, Tops Revenue Estimates
Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of -45.45% and +9.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Jul 30, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
IRVINE, Calif., July 30, 2025 ( GLOBE NEWSWIRE ) -- Tarsus Pharmaceuticals, Inc. ( NASDAQ: TARS ) , today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Wednesday, August 6, 2025, to report its second quarter 2025 financial results and provide a corporate update.
May 29, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Tarsus to Participate in Upcoming Investor Conferences
IRVINE, Calif., May 29, 2025 ( GLOBE NEWSWIRE ) -- Tarsus Pharmaceuticals, Inc. ( NASDAQ: TARS ) , today announced that management plans to participate in the following upcoming investor conferences: ...
May 29, 2025 • Benzinga SOMEWHAT-BULLISH
Tarsus to Participate in Upcoming Investor Conferences - Tarsus Pharmaceuticals ( NASDAQ:TARS )
IRVINE, Calif., May 29, 2025 ( GLOBE NEWSWIRE ) -- Tarsus Pharmaceuticals, Inc. TARS, today announced that management plans to participate in the following upcoming investor conferences: William Blair 45th Annual Growth Stock Conference on Tuesday, June 3rd, at 6:00 a.m. PT / 8:00 a.m. CT
May 14, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Tarsus Pharmaceuticals ( TARS ) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Tarsus Pharmaceuticals (TARS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend ...
May 08, 2025 • Benzinga SOMEWHAT-BULLISH
Tarsus to Participate in Upcoming Investor Conferences - Tarsus Pharmaceuticals ( NASDAQ:TARS )
IRVINE, Calif., May 08, 2025 ( GLOBE NEWSWIRE ) -- Tarsus Pharmaceuticals, Inc. TARS today announced that management plans to participate in the following upcoming investor conferences: Bank of America Securities 2025 Health Care Conference on Tuesday, May 13th, at 3:40 p.m. PT / 6:40 p.m. ET
Sentiment Snapshot

Average Sentiment Score:

0.275
50 articles with scored sentiment

Overall Sentiment:

Bullish

TARS Reported Earnings

Feb 25, 2025
Dec 31, 2024 (Pre market)
0.22 Surprise
  • Reported EPS: $-0.60
  • Estimate: $-0.82
  • Whisper: —
  • Surprise %: 26.4%
Nov 07, 2024
Sep 30, 2024 (Post market)
0.33 Surprise
  • Reported EPS: $-0.61
  • Estimate: $-0.94
  • Whisper: —
  • Surprise %: 35.1%
Aug 08, 2024
Jun 30, 2024 (Post market)
0.04 Surprise
  • Reported EPS: $-0.88
  • Estimate: $-0.92
  • Whisper: —
  • Surprise %: 4.3%
May 08, 2024
Mar 31, 2024 (Post market)
0.19 Surprise
  • Reported EPS: $-1.01
  • Estimate: $-1.20
  • Whisper: —
  • Surprise %: 15.8%
Feb 27, 2024
Dec 31, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $-1.31
  • Estimate: $-1.36
  • Whisper: —
  • Surprise %: 3.7%
Nov 09, 2023
Sep 30, 2023 (Post market)
0.09 Surprise
  • Reported EPS: $-1.28
  • Estimate: $-1.37
  • Whisper: —
  • Surprise %: 6.6%
Aug 10, 2023
Jun 30, 2023 (Post market)
-0.09 Surprise
  • Reported EPS: $-1.17
  • Estimate: $-1.08
  • Whisper: —
  • Surprise %: -8.3%
May 09, 2023
Mar 31, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $-0.88
  • Estimate: $-0.94
  • Whisper: —
  • Surprise %: 6.4%
Mar 13, 2023
Dec 31, 2022 (Post market)
0.2 Surprise
  • Reported EPS: $-0.49
  • Estimate: $-0.69
  • Whisper: —
  • Surprise %: 29.0%

Financials